154 related articles for article (PubMed ID: 1986986)
1. Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats.
Buchholz RA; Dundore RL; Cumiskey WR; Harris AL; Silver PJ
Hypertension; 1991 Jan; 17(1):91-100. PubMed ID: 1986986
[TBL] [Abstract][Full Text] [Related]
2. Hypotensive properties of the protein kinase inhibitor, staurosporine, in normotensive and spontaneously hypertensive rats.
Secrest RJ; Williams P; Bonjouklian R; Modlin D; Firman K; Turk J; Cohen ML
Clin Exp Hypertens A; 1991; 13(2):219-34. PubMed ID: 2065465
[TBL] [Abstract][Full Text] [Related]
3. Satellite cell myogenesis is highly stimulated by the kinase inhibitor iso-H7: comparison with HA1004 and staurosporine effects.
Lagord C; Carpentier G; Moraczewski J; Pons G; Climent F; Martelly I
Biochem Biophys Res Commun; 1993 Mar; 191(3):928-36. PubMed ID: 8466533
[TBL] [Abstract][Full Text] [Related]
4. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats.
Ruan X; Arendshorst WJ
Am J Physiol; 1996 Jun; 270(6 Pt 2):F945-52. PubMed ID: 8764313
[TBL] [Abstract][Full Text] [Related]
5. Staurosporine-related compounds, K252a and UCN-01, inhibit both cPKC and nPKC.
Mizuno K; Saido TC; Ohno S; Tamaoki T; Suzuki K
FEBS Lett; 1993 Sep; 330(2):114-6. PubMed ID: 8365480
[TBL] [Abstract][Full Text] [Related]
6. The effect of putative protein kinase C inhibitors, K252a and staurosporine, on the human neutrophil respiratory burst activated by both receptor stimulation and post-receptor mechanisms.
Twomey B; Muid RE; Dale MM
Br J Pharmacol; 1990 Aug; 100(4):819-25. PubMed ID: 2169942
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the involvement of protein kinase C in depression of endothelium-dependent vascular responses in spontaneously hypertensive rats.
Soloviev AI; Parshikov AV; Stefanov AV
J Vasc Res; 1998; 35(5):325-31. PubMed ID: 9789113
[TBL] [Abstract][Full Text] [Related]
8. Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine.
Falotico R; Keiser J; Haertlein B; Cheung WM; Tobia A
Proc Soc Exp Biol Med; 1989 Feb; 190(2):179-85. PubMed ID: 2915996
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of C6 glioma cells to radiation by staurosporine, a potent protein kinase C inhibitor.
Zhang W; Yamada H; Sakai N; Nozawa Y
J Neurooncol; 1993 Jan; 15(1):1-7. PubMed ID: 8455059
[TBL] [Abstract][Full Text] [Related]
10. The relaxant action of jatrophone in rat portal vein. A comparison with protein kinase C inhibitors.
Silva AM; Brum RL; Calixto JB
Life Sci; 1995; 57(9):863-71. PubMed ID: 7630315
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of cyclic AMP-dependent protein kinase, myosin light chain kinase and protein kinase C by azaacridine and acridine derivatives.
Chen Q; Deady LW; Polya GM
Biol Chem Hoppe Seyler; 1994 Apr; 375(4):223-35. PubMed ID: 8060530
[TBL] [Abstract][Full Text] [Related]
12. Participation of protein kinases in staurosporine-induced interleukin-6 production by rat peritoneal macrophages.
Yamaki K; Ohuchi K
Br J Pharmacol; 1999 Jul; 127(6):1309-16. PubMed ID: 10455280
[TBL] [Abstract][Full Text] [Related]
13. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
14. Reversible G1 arrest of a human lung epithelial cell line by staurosporine.
Lin Y; Chrest FJ; Gabrielson EW
J Cell Physiol; 1992 Sep; 152(3):646-53. PubMed ID: 1506420
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
16. K252a is a potent and selective inhibitor of phosphorylase kinase.
Elliott LH; Wilkinson SE; Sedgwick AD; Hill CH; Lawton G; Davis PD; Nixon JS
Biochem Biophys Res Commun; 1990 Aug; 171(1):148-54. PubMed ID: 2393389
[TBL] [Abstract][Full Text] [Related]
17. AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats.
Ford RJ; Teschke SR; Reid EB; Durham KK; Kroetsch JT; Rush JW
J Hypertens; 2012 Apr; 30(4):725-33. PubMed ID: 22306847
[TBL] [Abstract][Full Text] [Related]
18. Effect of protein kinase C and protein kinase A inhibitors on contraction of isolated femoral arteries of SHR and Wistar rats.
Bal MS; Paulis L; Zicha J; Kunes J
Physiol Res; 2009; 58(6):793-798. PubMed ID: 19093737
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C; Budworth J; Gescher A
Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
[TBL] [Abstract][Full Text] [Related]
20. Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension.
Bilder GE; Kasiewski CJ; Perrone MH
J Pharmacol Exp Ther; 1990 Feb; 252(2):526-30. PubMed ID: 2313587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
